# NPW

## Overview
Neuropeptide W (NPW) is a gene that encodes a regulatory peptide involved in a variety of physiological processes. The NPW gene undergoes proteolytic processing to produce two mature peptide forms, NPW23 and NPW30, which are characterized by their N-terminal tryptophan residues. These peptides function primarily through their interaction with G protein-coupled receptors GPR7 and GPR8, also known as NPBWR1 and NPBWR2, playing a crucial role in neuronal signaling pathways (Tanaka2003Characterization; Shimomura2002Identification). Neuropeptide W is implicated in the regulation of neuroendocrine axes, feeding behavior, energy homeostasis, and cardiovascular functions, with significant expression in the central nervous system and various peripheral tissues (Chottova2018Distribution; Singh2006Neuropeptide). The dysregulation of NPW signaling has been associated with clinical conditions such as obesity, diabetes, and stress-related disorders, highlighting its importance in maintaining physiological balance (Chottova2018Distribution; Pandey2022Regulation).

## Structure
Neuropeptide W (NPW) is a peptide derived from a precursor protein that undergoes proteolytic processing to generate two mature forms: NPW23 and NPW30, consisting of 23 and 30 amino acids, respectively (Tanaka2003Characterization; Shimomura2002Identification). The primary structure of NPW includes a characteristic N-terminal tryptophan residue, which is crucial for its function (Tanaka2003Characterization). The sequence of NPW23 is identical to the N-terminal 23 residues of NPW30, indicating that NPW30 is an extended form of NPW23 (Shimomura2002Identification).

The secondary structure of NPW is not explicitly detailed in the available literature, but the presence of tryptophan residues at both the N- and C-terminal regions suggests potential structural motifs important for receptor binding (Chottova2018Distribution). The tertiary and quaternary structures of NPW have not been described in the context provided.

NPW is known to interact with G protein-coupled receptors GPR7 and GPR8, indicating its role in signaling pathways (Tanaka2003Characterization). The peptide's function is influenced by its structural features, particularly the N-terminal region, which is essential for receptor binding and interaction (Chottova2018Distribution).

## Function
Neuropeptide W (NPW) is a regulatory peptide that plays a significant role in various physiological processes in healthy human cells. It acts primarily through the G-protein-coupled receptors GPR7 and GPR8, also known as NPBWR1 and NPBWR2, influencing neuronal signaling pathways (Chottova2018Distribution; Shimomura2002Identification). NPW is involved in the central regulation of neuroendocrine axes, feeding behavior, energy homeostasis, and cardiovascular functions (Chottova2018Distribution). 

In the central nervous system, NPW is highly expressed in regions such as the substantia nigra, amygdala, and hippocampus, where it modulates emotional responses and feeding behavior (Singh2006Neuropeptide; Chottova2018Distribution). NPW influences the hypothalamic-pituitary-adrenal axis, affecting stress hormone secretion and energy expenditure (Taylor2005Actions; Mondal2006Neuropeptide). 

In peripheral tissues, NPW is expressed in various endocrine glands, including the adrenal gland and pancreas, where it regulates hormone secretion and energy metabolism (Chottova2018Distribution). It also affects adipocyte function, potentially alleviating leptin resistance associated with obesity (Chottova2018Distribution). NPW's role in these processes highlights its importance in maintaining physiological balance and responding to metabolic demands.

## Clinical Significance
Alterations in the expression or function of the NPW gene have been linked to several clinical conditions. In the context of diabetes, particularly type 2 diabetes mellitus (DM), changes in the NPW signaling system have been observed. In diabetic rats, NPW expression is upregulated in the left atrium, which may contribute to cardiac dysfunction associated with diabetes (Pandey2022Regulation). Additionally, NPW has been implicated in energy homeostasis and feeding behavior. Disruption in NPW signaling can lead to obesity, as seen in studies where NPW administration resulted in hyperphagia in rats (Singh2006Neuropeptide). 

NPW is also involved in emotional regulation and stress response. Dysfunction in NPW signaling can lead to exaggerated autonomic and neuroendocrine responses, as well as impaired behavioral responses to stress, as observed in NPW gene knockout mice (Chottova2018Distribution). Furthermore, NPW has been associated with pain modulation, with alterations in its signaling linked to hyperalgesia in response to acute inflammatory pain (Chottova2018Distribution). These findings suggest that NPW plays a significant role in various physiological processes, and its dysregulation may contribute to the pathogenesis of several disorders.

## Interactions
Neuropeptide W (NPW) is known to interact with G protein-coupled receptors GPR7 and GPR8, which are involved in various physiological processes, including feeding regulation and energy homeostasis. NPW acts as an endogenous ligand for these receptors, coupling to Gαi proteins and inhibiting forskolin-induced cAMP accumulation in cells expressing GPR7 and GPR8 (Tanaka2003Characterization; Shimomura2002Identification). 

In the brain, NPW-containing neurons are found in the lateral hypothalamus, where they interact with orexin and melanin-concentrating hormone (MCH) neurons. This interaction suggests a role for NPW in modulating feeding and sleep/arousal behaviors (Takenoya2008Neuronal). Immunohistochemical studies have shown that NPW-like immunoreactive fibers are in direct contact with orexin-containing neurons and MCH-containing neuronal cell bodies and processes, indicating a potential regulatory mechanism involving these neuropeptides (Takenoya2008Neuronal).

NPW also influences prolactin release and food intake when administered intracerebroventricularly in rats, highlighting its role in the central control of feeding and the neuroendocrine system (Shimomura2002Identification). These interactions underscore the significance of NPW in the central nervous system and its potential as a target for therapeutic interventions.


## References


[1. (Singh2006Neuropeptide) Gurminder Singh and Anthony P Davenport. Neuropeptide b and w: neurotransmitters in an emerging g‐protein‐coupled receptor system. British Journal of Pharmacology, 148(8):1033–1041, August 2006. URL: http://dx.doi.org/10.1038/sj.bjp.0706825, doi:10.1038/sj.bjp.0706825. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.bjp.0706825)

[2. (Tanaka2003Characterization) Hirokazu Tanaka, Tetsuo Yoshida, Norimasa Miyamoto, Toshiyuki Motoike, Hiroshi Kurosu, Kenji Shibata, Akihiro Yamanaka, S. Clay Williams, James A. Richardson, Natsuko Tsujino, Mary G. Garry, Michael R. Lerner, David S. King, Brian F. O’Dowd, Takeshi Sakurai, and Masashi Yanagisawa. Characterization of a family of endogenous neuropeptide ligands for the g protein-coupled receptors gpr7 and gpr8. Proceedings of the National Academy of Sciences, 100(10):6251–6256, April 2003. URL: http://dx.doi.org/10.1073/pnas.0837789100, doi:10.1073/pnas.0837789100. This article has 156 citations.](https://doi.org/10.1073/pnas.0837789100)

[3. (Mondal2006Neuropeptide) M S Mondal, H Yamaguchi, Y Date, K Toshinai, T Kawagoe, T Tsuruta, H Kageyama, Y Kawamura, S Shioda, Y Shimomura, M Mori, and M Nakazato. Neuropeptide w is present in antral g cells of rat, mouse, and human stomach. Journal of Endocrinology, 188(1):49–57, January 2006. URL: http://dx.doi.org/10.1677/joe.1.06195, doi:10.1677/joe.1.06195. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1677/joe.1.06195)

[4. (Takenoya2008Neuronal) Fumiko Takenoya, Shinji Kitamura, Haruaki Kageyama, Naoko Nonaka, Mayumi Seki, Kazuo Itabashi, Yukari Date, Masamitsu Nakazato, and Seiji Shioda. Neuronal interactions between neuropeptide w- and orexin- or melanin-concentrating hormone-containing neurons in the rat hypothalamus. Regulatory Peptides, 145(1–3):159–164, January 2008. URL: http://dx.doi.org/10.1016/j.regpep.2007.08.015, doi:10.1016/j.regpep.2007.08.015. This article has 16 citations.](https://doi.org/10.1016/j.regpep.2007.08.015)

[5. (Shimomura2002Identification) Yukio Shimomura, Mioko Harada, Mika Goto, Tsukasa Sugo, Yoshio Matsumoto, Michiko Abe, Takuya Watanabe, Taiji Asami, Chieko Kitada, Masaaki Mori, Haruo Onda, and Masahiko Fujino. Identification of neuropeptide w as the endogenous ligand for orphan g-protein-coupled receptors gpr7 and gpr8. Journal of Biological Chemistry, 277(39):35826–35832, September 2002. URL: http://dx.doi.org/10.1074/jbc.m205337200, doi:10.1074/jbc.m205337200. This article has 143 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m205337200)

[6. (Chottova2018Distribution) Magdalena Chottova Dvorakova. Distribution and function of neuropeptides w/b signaling system. Frontiers in Physiology, July 2018. URL: http://dx.doi.org/10.3389/fphys.2018.00981, doi:10.3389/fphys.2018.00981. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2018.00981)

[7. (Pandey2022Regulation) Shashank Pandey, Dagmar Jarkovska, Zdenek Tuma, Tereza Smrhova, and Magdalena Chottova Dvorakova. Regulation of prepro-neuropeptidew/b and its receptor in the heart of zdf rats: an animal model of type ii dm. International Journal of Molecular Sciences, 23(23):15219, December 2022. URL: http://dx.doi.org/10.3390/ijms232315219, doi:10.3390/ijms232315219. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms232315219)

[8. (Taylor2005Actions) Meghan M. Taylor, Erik A. Yuill, Jennifer R. Baker, Catharine C. Ferri, Alastair V. Ferguson, and Willis K. Samson. Actions of neuropeptide w in paraventricular hypothalamus: implications for the control of stress hormone secretion. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 288(1):R270–R275, January 2005. URL: http://dx.doi.org/10.1152/ajpregu.00396.2004, doi:10.1152/ajpregu.00396.2004. This article has 29 citations.](https://doi.org/10.1152/ajpregu.00396.2004)